Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Blood
|
May 23, 2001
Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system
I D Lewis, G Almeida-Porada, J Du, et al.
Blood
|
January 7, 1998
Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice
P O Iversen, I D Lewis, S Turczynowicz, et al.
Leukemia
|
January 20, 2009
Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation
M Perugini, C H Kok, A L Brown, et al.
Leukemia
|
November 29, 2012
GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations
M Perugini, D G Iarossi, C H Kok, et al.
Leukemia
|
February 10, 2016
Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia
J R Lynch, H Yi, D A Casolari, et al.
Leukemia
|
April 30, 2015
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML
C E Forristal, A L Brown, F M Helwani, et al.
Scientific Reports
|
May 28, 2017
A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm
D A Casolari, T Nguyen, C M Butcher, et al.
Leukemia
|
March 10, 2015
A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone
C N Hahn, D M Ross, J Feng, et al.
Leukemia
|
July 5, 2017
A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients
D Beck, J A I Thoms, C Palu, et al.
Leukemia
|
August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
V Bachanova, D I Marks, M-J Zhang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Blood
|
May 23, 2001
Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system
I D Lewis, G Almeida-Porada, J Du, et al.
Blood
|
January 7, 1998
Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice
P O Iversen, I D Lewis, S Turczynowicz, et al.
Leukemia
|
January 20, 2009
Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation
M Perugini, C H Kok, A L Brown, et al.
Leukemia
|
November 29, 2012
GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations
M Perugini, D G Iarossi, C H Kok, et al.
Leukemia
|
February 10, 2016
Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia
J R Lynch, H Yi, D A Casolari, et al.
Leukemia
|
April 30, 2015
Hypoxia inducible factor (HIF)-2α accelerates disease progression in mouse models of leukemia and lymphoma but is not a poor prognosis factor in human AML
C E Forristal, A L Brown, F M Helwani, et al.
Scientific Reports
|
May 28, 2017
A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm
D A Casolari, T Nguyen, C M Butcher, et al.
Leukemia
|
March 10, 2015
A tale of two siblings: two cases of AML arising from a single pre-leukemic DNMT3A mutant clone
C N Hahn, D M Ross, J Feng, et al.
Leukemia
|
July 5, 2017
A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients
D Beck, J A I Thoms, C Palu, et al.
Leukemia
|
August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
V Bachanova, D I Marks, M-J Zhang, et al.
Page
of 3